Research & Development



  歷史上的霍去病顯得很獨,現在不一樣了,他至少跟李敢已經成了好朋友,估計干不出一箭射殺李敢的事情了。   “你怎麼知道我想打死你?”大香蕉网站   雲瑯剛剛走進中軍府衙,就听見里面傳來一陣激辯之聲,緊接著幾個衣衫破舊的老軍就被幾個護衛推推搡搡趕了出來。中文字幕大香蕉在线   眼看著他老婆跟張湯調情,他還一個勁的勸雲瑯喝酒……   “治病的藥,只看對癥不對癥,可不看名貴不名貴。曹襄患病時間已經很長了,肚子鼓大,這是明顯的肝部受損癥狀,還需要配上野三七幫他補肝才好。”青青草AV在线视频观免   張湯家的漂亮食盒每隔五天就會到來一次……

Our discovery and development platforms for drug and cell-based therapies allow us to both create and retain significant value within our therapeutic franchise areas of cancer and inflammatory diseases. Scientists and physicians at Celgene are the driving force behind our success, enabling target-to-therapeutic platforms that integrate both small-molecule and cell-based therapies.

Connect? Registries

The Connect??Registries are observational, hematologic patient registry studies in Multiple Myeloma (Connect?MM), Chronic Lymphocytic Leukemia (Connect?CLL) and Myelodysplastic Syndromes/Acute Myeloid Leukemia (Connect?MDS/AML) and are sponsored by Celgene Corporation. These studies are designed to observe the routine care of patients through the course of their disease. Unlike clinical trials, registries do not require or provide any specific medications or healthcare services, but leave those decisions to the treating doctors and their patients.
Connect? Registries logo